Latest Regulatory News

AuKing Mining announces the immediate retirement of two board members and reveals a legal dispute involving Orion Resources over the Cloncurry Gold Project, leading to a halt in their planned acquisition.

The Foreign Investment Review Board has extended its deadline to assess Caterpillar’s proposed acquisition of RPMGlobal, pushing the decision to 23 January 2026. This procedural extension keeps the deal on track but leaves some questions open for shareholders.

Ragnar Metals has confirmed high-grade uranium mineralisation at surface over a 150m strike at its Klockartorpet Project in Sweden, revealing a 1km long uranium anomaly and multiple untested targets. The findings set the stage for further exploration and drilling plans.

NeuroScientific Biopharmaceuticals reports encouraging clinical responses in fistulising Crohn’s disease patients treated under Australia’s Special Access Scheme, setting the stage for pivotal Phase 2 trials later this year.

McLaren Minerals’ Pre-Feasibility Study confirms a robust, low-risk titanium mining project in Western Australia, projecting nearly A$900 million EBITDA over 16 years. The study highlights strong market demand and validated processing methods, setting the stage for the next development phase.

RareX Limited has achieved a major regulatory milestone with the granting of a Mining Lease for its Cummins Range Project in Western Australia, significantly reducing development risk and paving the way for focused metallurgical optimisation and mine planning.

Horizon Oil has approved a strategic $1.5 million investment to install a booster compressor at its Nam Phong gas field in Thailand, aiming to increase production by at least 40% by mid-2026.

Osmond Resources is fast-tracking development of its Orión EU Critical Minerals Project, with initial drilling confirming high-grade titanium, zircon, and rare earth elements. The company aims to complete a maiden Mineral Resource Estimate and Scoping Study by mid-2026.

AdAlta Limited has raised A$1.2 million through a strategic placement to advance its innovative PD1 armored MSLN CAR-T therapy for solid cancers, reinforcing its unique 'East to West' cellular immunotherapy approach.

Ore Resources Ltd has identified nine promising gold targets at its Randalls North tenements through detailed geophysical and geochemical analysis, setting the stage for an active 2026 exploration campaign.

Tetratherix has successfully completed the second safety review of its TetraDerm clinical trial's second cohort, showing no adverse events and confirming a strong safety profile. The trial now progresses to its final phase, targeting a growing reconstructive surgery market.

Forrestania Resources has agreed to acquire Catalina Resources’ Laverton Project, swapping its Breakaway Dam copper asset and gaining a significant equity stake in Catalina. This move strategically broadens Forrestania’s presence in the Eastern Goldfields gold belt.